Soru

Zorluk: OrtaInterpreting Laboratory Results

A 32-year-old woman is evaluated in the clinic for right lower extremity swelling and pain that began two days ago. Venous Doppler ultrasonography confirms an acute deep vein thrombosis in the right popliteal vein. Her past medical history is significant for a spontaneous abortion at 14 weeks gestation two years ago. She takes no medications and has no family history of bleeding or clotting disorders. Physical examination is unremarkable except for moderate right calf swelling and tenderness.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin13.2 g/dL12.0-16.0 g/dL
Platelet count210,000/mm³150,000-400,000/mm³
Prothrombin time (PT)12.5 seconds11-15 seconds
Activated partial thromboplastin time (aPTT)62 seconds25-40 seconds

A 1:11:1 mixing study with normal pooled plasma is performed. Immediately after mixing, the patient's aPTT is 58 seconds.

Based on these laboratory findings, which of the following is the most likely diagnosis?

  1. Antiphospholipid syndromeCevap
  2. B
    Factor VIII deficiency
  3. C
    Factor V Leiden mutation
  4. D
    Anti-factor VIII autoantibody
  5. E
    Von Willebrand disease

Cevap

Antiphospholipid syndrome
The correct diagnosis is antiphospholipid syndrome. This patient presents with a history of recurrent thrombotic events (deep vein thrombosis and a second-trimester miscarriage). Her laboratory workup reveals an isolated prolonged aPTT. The crucial diagnostic step is the 1:1 mixing study with normal pooled plasma, which fails to correct the aPTT. This failure to correct indicates the presence of a circulating inhibitor in the patient's serum that inhibits the coagulation cascade in the laboratory assay. The lupus anticoagulant is an antiphospholipid antibody that binds to the phospholipids used in the aPTT test, artificially prolonging the result. Despite this in vitro prolongation, lupus anticoagulant is paradoxically prothrombotic in vivo, perfectly matching this patient's clinical presentation.

Adım Adım Çözüm

1
Analyze the baseline coagulation profile.
The patient has an isolated prolongation of the activated partial thromboplastin time (aPTT) with a normal prothrombin time (PT) and normal platelet count.
Identifying the specific pathway abnormality (intrinsic vs. extrinsic vs. common) is the first step in diagnosing a coagulopathy.
2
Interpret the results of the 1:1 mixing study.
The aPTT remains prolonged (58 seconds) despite the addition of normal pooled plasma.
A failure to correct indicates the presence of a coagulation inhibitor (e.g., lupus anticoagulant or specific factor inhibitor) rather than a simple factor deficiency.
3
Synthesize the laboratory data with the clinical scenario.
The patient has a circulating inhibitor in the setting of deep vein thrombosis and a history of mid-trimester spontaneous abortion.
Lupus anticoagulant acts as an inhibitor in vitro (prolonging the aPTT) but is strongly prothrombotic in vivo, characteristic of antiphospholipid syndrome.

Anahtar Kavram

In evaluating an isolated prolonged aPTT, a mixing study differentiates between a factor deficiency (which corrects) and an inhibitor (which does not correct). A non-correcting mixing study in a patient with thrombosis strongly suggests lupus anticoagulant associated with antiphospholipid syndrome.
Bu soruyu puanla